Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1998-04-09
2000-07-04
Owens, Amelia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514532, 514543, 514544, 514570, 560 60, 562470, A61K 31215, A61K 31235, A61K 3119
Patent
active
060839821
ABSTRACT:
Compounds, methods and compositions are provided for inducing natriuresis in a mammal. Methods for isolating and synthesizing the natriuretic compounds are also provided. Therapeutic methods using the natriuretic compounds are also provided. The natriuretic compounds are capable of inducing sodium excretion in a mammal without inducing corresponding prolonged potassium excretion.
REFERENCES:
patent: 3726904 (1973-04-01), Habicht, et al.
patent: 3947473 (1976-03-01), Scott et al.
patent: 4003919 (1977-01-01), Scott et al.
patent: 4018799 (1977-04-01), Scott et al.
patent: 4026907 (1977-05-01), Scott et al.
patent: 4237130 (1980-12-01), Cragoe, et al.
patent: 4321270 (1982-03-01), Sundeen
Chemical Abstract: 106:84395 (1985).
Chemical Abstract: 120:266482 (1993).
Kenji Fukuzawa, Yasuo Suzuki, Mitsuru Uchiyama; Modified Lipophilic Vitamin II Effect of Tocopheronolactone on Lipid-Peroxidation; Chemical & Pharmaceutical Bulletin, Sep. 1969, vol. 17, No. 9, pp. 1771-1777.
Noal Cohen, Rocco Lopresti, Gabriel Saucy: A Novel Total Synthesis of (2R,4'R,8'R)-.alpha.-Tocopherol (Vitamin E), Construction of Chiral Chromans from an Optically Active, Nonaromaic Precursor; Journal of the American Chemical Society, 101:22, Oct. 24, 1979, pp. 6710-6716.
U. Gloor, J. Wursch, U. Schwieter, O. Wiss; Resorption, Retention, Verteilung und Stoffwechsel des D,L-.alpha.-Tocopheramins, d,l-N-Methyl-y-Tocopheramins und des y-Tocopherols im Vergleich zum d,l-.alpha.-Tocopherol bei der Ratte; Helvetica Chimica Acta, vol. 49, 1966, No. 266-267, pp. 2303-2312.
Chemical Abstracts, vol. 72, 1970, pp. 383-384; 78856q and JP, A, 6 927 026 (Taisho Pharmaceutical.) Nov. 11, 1969; Tocopheronolactone.
Chemical Abstracts, p. 2845, vol. 68, 1968; 29435k and JP, A, 1 303 467 (Yamanouchi) Jul. 28, 1967; Novel toluquinone derivatives.
Chemical Abstracts, p. 2512, vol. 69, 1968; 27057k and JP, A, 6 723 024 (Yamanouchi) Nov. 9, 1967; Novel 3,4-dimethoxytoluquinones.
27-Heterocyclic, p. 615, vol. 98, 1983; 98:71933r and JP, A, 57 145 871 (Eisai) Sep. 9, 1982; Hydroxychromanpropionic acid derivatives.
Chemical Abstracts, p. 416, vol. 100, 1984; 100:136378v and J. Lipid Res., vol. 25, No. 1, 1984, Engl., pp. 40-48; Novel uninary metabolite of d-.delta.-tocopherol in rats.
Chemical Abstracts, p. 490, vol. 81, 1974; 151742s and Chem. Pharm. Bull., vol. 22, No. 3, 1974, JP pp. 566-575: Ubuquinone and related compounds.
M. A. Petty, et al.; "Myocardial Protection by a Cardioselctive Free Radical Scavenger"; European Journal of Pharmacology; 255 (1994) 215-222.
Derwent Abstract of JP 63208557 (A).
Free Radical Biology & Medicine, Vol. 16 No. 4; "Reduction of Myocardial infarct Size in Rat by IRFI-048, A Selective Analogue of Vitamine E".
Pharmacology 1994; 48 pp. 157-166; "Protective Effects of IRFI-016, a New Antioxidant Agent, in Myocardial Damage, following Coronary Artery Occlusion and Reperfusion in the Rat".
Research Communications in Chemical Pathology and Pharmacology, Vol. 76, No. 3, pp. 287-303, June 1992; "IRFI-016, A New Radical Scavenger, Limits Ischemic Damage Following Coronary Artery Occlusion in Rats".
Benaksas Elaine J.
Kantoci Darko
Levine Barry H.
Murray David E.
Wechter William J.
Loma Linda University Medical
Owens Amelia
LandOfFree
Natriuretic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Natriuretic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Natriuretic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1486990